Pharmaceutical antiaging solutions targeting sun damage and pigmentation.
Sun damage shows up as several different things — melasma patches, age spots, blotchy tone, marks left by inflammation, and rough precancerous patches — and each has its own best treatment. Sunscreen prevents all of them and every treatment relapses without it. Tretinoin helps blotchy tone and spots; hydroquinone and the triple-combination cream are the best-proven melasma treatments in courses; oral tranexamic acid helps stubborn melasma; azelaic acid is the gentle option; 5-fluorouracil and similar treat precancerous patches; lasers clear age spots but can worsen melasma.
Sun damage and pigmentation are several distinct problems — melasma, solar lentigines, diffuse mottling, post-inflammatory hyperpigmentation, and precancerous actinic damage — and the pharmaceuticals rank by randomised evidence for each: daily sunscreen first, because it prevents all of them and is the only agent proven to reduce future photoageing; tretinoin second, for mottled pigmentation, lentigines and texture together; hydroquinone and the triple combination third, the most effective treatment for melasma in trials, used in time-limited courses; oral tranexamic acid fourth, for melasma resistant to topicals, after a clotting screen; azelaic acid fifth, the gentler, pregnancy-safe option; field treatments — topical 5-fluorouracil, imiquimod, photodynamic therapy — for actinic keratoses, which are sun damage with cancer risk rather than a cosmetic concern, with strong randomised evidence; oral nicotinamide for people with prior skin cancers; and lasers and peels, which clear lentigines and refine texture with results and risks that depend on skin type and operator. Over-the-counter vitamin C, niacinamide and kojic acid are adjuncts. Every treatment relapses without sunscreen, because the cause is still there.
- Pigmentation is not one diagnosis; melasma, lentigines, post-inflammatory marks and actinic damage have different best-evidenced treatments and the wrong one does nothing.
- Sunscreen is treatment as well as prevention: every depigmenting trial that worked ran on top of it, and every result relapses without it.
- Hydroquinone remains the best-evidenced melasma agent and must be used in courses; the triple combination is stronger and also time-limited.
- Actinic keratoses are sun damage with cancer risk and have their own strong randomised evidence base — 5-fluorouracil, imiquimod, photodynamic therapy — that is not cosmetic.
- Lasers can clear lentigines quickly and can worsen melasma; the diagnosis decides the device.
Pharmaceuticals for sun damage and pigmentation, ranked
Ranked on: randomised human evidence for the specific form of sun damage or pigmentation each agent treats, weighted by trial size and quality, the breadth of what it treats, and the safety limits on its use.
| # | Option | Verdict | Grade |
|---|---|---|---|
| 1 | Daily broad-spectrum sunscreen | Prevents every item below; the base of every trial that worked | GRADE AEstablished |
| 2 | Tretinoin (topical) | Mottled pigmentation, lentigines and texture together | GRADE AEstablished |
| 3 | Hydroquinone and the triple combination (hydroquinone + tretinoin + corticosteroid) | The most effective melasma treatment in trials; time-limited | GRADE AEstablished |
| 4 | Oral tranexamic acid | Melasma resistant to topicals; clotting screen required | GRADE BPromising |
| 5 | Azelaic acid (prescription strength) | Gentler, pregnancy-safe, less effective | GRADE BPromising |
| 6 | Field treatments for actinic keratoses — 5-fluorouracil, imiquimod, photodynamic therapy | Strong randomised evidence for precancerous sun damage | GRADE AEstablished |
| 7 | Oral nicotinamide for prior skin-cancer patients | Fewer new non-melanoma cancers in a randomised trial | GRADE BPromising |
| 8 | Lasers and light devices — Q-switched, picosecond, IPL, fractional | Clear lentigines; can worsen melasma; skin type decides | GRADE BPromising |
| 9 | Chemical peels — glycolic, salicylic, TCA | Adjunct for lentigines and texture; depth-dependent | GRADE BPromising |
| 10 | Over-the-counter adjuncts — vitamin C, niacinamide, kojic acid, arbutin, licorice extract | Modest lightening; useful around the prescriptions | GRADE CEarly |
- 01
Daily broad-spectrum sunscreen
GRADE AEstablishedPrevents every item below; the base of every trial that workedRandomised evidence for less photoageing over four and a half years and for fewer skin cancers; every depigmenting trial that succeeded used it in both arms, and every result relapses without it. Tinted or iron-oxide-containing sunscreens add visible-light protection that matters specifically for melasma.
- 02
Tretinoin (topical)
GRADE AEstablishedMottled pigmentation, lentigines and texture togetherRandomised, vehicle-controlled trials show lightening of mottled hyperpigmentation and solar lentigines alongside wrinkle and texture improvement over six to twelve months. The broadest single agent for diffuse sun damage; also a component of the melasma triple combination.
- 03
Hydroquinone and the triple combination (hydroquinone + tretinoin + corticosteroid)
GRADE AEstablishedThe most effective melasma treatment in trials; time-limitedHydroquinone alone clears melasma and lentigines in randomised trials; the triple combination outperforms any two of its components. Used in courses of a few months because of ochronosis risk with prolonged use; restricted or prescription-only in many countries. The standard against which other melasma agents are measured.
- 04
Oral tranexamic acid
GRADE BPromisingMelasma resistant to topicals; clotting screen requiredLow-dose oral tranexamic acid improves melasma in randomised trials over eight to twelve weeks, with relapse on stopping and additive benefit with topicals. Contraindicated with a history of thromboembolism and interacting with hormonal contraception; a clinician's screening is the reason it is B rather than A.
- 05
Azelaic acid (prescription strength)
GRADE BPromisingGentler, pregnancy-safe, less effectiveRandomised trials in melasma show improvement comparable to lower-strength hydroquinone with a milder profile, and it is usable in pregnancy and in post-inflammatory hyperpigmentation. The choice when hydroquinone and retinoids are unsuitable.
- 06
Field treatments for actinic keratoses — 5-fluorouracil, imiquimod, photodynamic therapy
GRADE AEstablishedStrong randomised evidence for precancerous sun damageActinic keratoses are sun damage with a risk of progression to squamous-cell carcinoma, and topical 5-fluorouracil, imiquimod and photodynamic therapy clear them in randomised trials, with 5-fluorouracil the most effective in head-to-head comparison. Not cosmetic; the most important treatment on this page for anyone who has them, and a dermatologist's diagnosis.
- 07
Oral nicotinamide for prior skin-cancer patients
GRADE BPromisingFewer new non-melanoma cancers in a randomised trialIn adults with at least two prior non-melanoma skin cancers, 500 mg twice daily reduced new cancers by about a quarter over a year; no persisting effect after stopping and no evidence in lower-risk people. A pharmaceutical for a defined high-risk group.
- 08
Lasers and light devices — Q-switched, picosecond, IPL, fractional
GRADE BPromisingClear lentigines; can worsen melasma; skin type decidesControlled trials show rapid clearance of solar lentigines and diffuse redness with appropriate devices, with pigmentation risk in darker skin types and a well-documented tendency to worsen melasma. The diagnosis chooses the device, and the operator determines the outcome.
- 09
Chemical peels — glycolic, salicylic, TCA
GRADE BPromisingAdjunct for lentigines and texture; depth-dependentSuperficial peels have controlled trials as adjuncts to topical depigmenting therapy; deeper peels treat lentigines and texture with more downtime and pigmentation risk. Operator- and skin-type-dependent.
- 10
Over-the-counter adjuncts — vitamin C, niacinamide, kojic acid, arbutin, licorice extract
GRADE CEarlyModest lightening; useful around the prescriptionsSmall trials show modest improvements in tone and mild hyperpigmentation. Useful between hydroquinone courses and as maintenance under sunscreen; not treatments for melasma or lentigines on their own.
Which pigmentation, which pharmaceutical
Diagnosis first
| Diagnosis | What it looks like | First-line pharmaceutical | Second line | What makes it worse |
|---|---|---|---|---|
| Melasma | Symmetric patches on cheeks, forehead, upper lip; hormonal and sun-driven | Triple combination or hydroquinone course, on tinted sunscreen | Oral tranexamic acid; azelaic acid; superficial peels | Sun and visible light; heat; many lasers; hormonal contraception |
| Solar lentigines | Discrete flat brown spots on sun-exposed skin | Tretinoin; hydroquinone spot treatment | Q-switched or picosecond laser; cryotherapy; peels | Sun |
| Diffuse mottling | Uneven tone across photoaged skin | Tretinoin | Vitamin C, niacinamide; IPL in fair skin | Sun |
| Post-inflammatory hyperpigmentation | Marks after acne, injury or irritation | Azelaic acid; tretinoin; sunscreen | Hydroquinone course; niacinamide | Sun; further irritation — including over-aggressive treatment |
| Actinic keratoses | Rough, scaly patches on chronically sun-exposed skin | 5-fluorouracil field treatment; a dermatologist's assessment | Imiquimod; photodynamic therapy; cryotherapy for isolated lesions | Sun; delay — these are precancerous |
Frequently asked questions
What pharmaceuticals treat sun damage and pigmentation?
Ranked on randomised evidence: daily sunscreen (prevents all forms and underlies every successful trial); tretinoin for mottled pigmentation and lentigines; hydroquinone and the triple combination for melasma in time-limited courses; oral tranexamic acid for resistant melasma after a clotting screen; azelaic acid as the gentle, pregnancy-safe option; 5-fluorouracil, imiquimod or photodynamic therapy for precancerous actinic keratoses; nicotinamide for prior skin-cancer patients; lasers and peels for lentigines and texture. The diagnosis decides which.
What is the most effective treatment for melasma?
The triple combination of hydroquinone, tretinoin and a mild corticosteroid, in a time-limited course on top of a tinted broad-spectrum sunscreen, outperforms any two of its components in randomised trials. Oral tranexamic acid adds benefit for resistant cases after a clotting-history screen. Melasma relapses with sun and visible light and is maintained rather than cured; lasers and aggressive peels often worsen it.
Is hydroquinone safe?
In courses of a few months, yes — it is the best-evidenced depigmenting agent. Prolonged continuous use risks exogenous ochronosis, a paradoxical bluish-black darkening that is hard to treat, which is why it is used in cycles with azelaic acid or other agents between, and why it is prescription-only or restricted in many countries.
Can lasers remove sun spots?
Solar lentigines respond well to Q-switched and picosecond lasers and to IPL in fair skin, with controlled trials showing rapid clearance; pigmentation risk rises in darker skin types and the operator matters. The same devices frequently worsen melasma, which is why the diagnosis — spot or patch — has to come before the device.
What are actinic keratoses and how are they treated?
Rough, scaly patches on chronically sun-exposed skin that are precancerous, with a risk of progressing to squamous-cell carcinoma. Field treatments — topical 5-fluorouracil (the most effective in head-to-head trials), imiquimod and photodynamic therapy — clear them in randomised trials. They need a dermatologist's diagnosis and are not a cosmetic concern to treat with brighteners.
Do vitamin C or niacinamide fix pigmentation?
They lighten mild hyperpigmentation modestly in small trials and are useful as maintenance under sunscreen and between hydroquinone courses. They do not treat melasma or lentigines on their own, and used in place of the prescriptions they mostly delay effective treatment.
Keep reading
- What antiaging pharmaceuticals work best for skin rejuvenation?
The same agents across all five rejuvenation outcomes.
- Doctor-recommended antiaging pharmaceuticals for long-term skin health
Sunscreen, nicotinamide and the long view.
- Early disease detection
Skin-cancer screening and where actinic damage fits.
- Skincare, graded
Every skincare intervention on the site by evidence tier.
More in Anti-aging pharma
- Is there a pill that can make you live to 150?
No pill has ever extended human lifespan in a trial. Here is what the compounds behind the 'live to 150' headlines actually proved, and in which species.
- Rapamycin for longevity: what the human evidence actually shows
The only 48-week human trial (PEARL, n=129) missed its primary endpoint. What rapamycin has actually shown, the real risks, and who should never take it.
- What are the most effective antiaging prescription treatments available?
Tretinoin, botulinum toxin and statins rank on randomised evidence above rapamycin, metformin and senolytics, which lack trial evidence for anti-ageing use.
- Which antiaging medicines deliver clinically proven wrinkle reduction results?
Botulinum toxin has the largest measured effect on dynamic wrinkles in randomised trials, ahead of tretinoin for photoaging and fillers for static folds.
- What antiaging pharmaceuticals work best for skin rejuvenation?
Tretinoin ranks first for skin rejuvenation, improving texture, fine wrinkles, and pigmentation in decades of trials, ahead of hydroquinone and Botox.
- Which doctor-prescribed antiaging drugs are safest long term?
Statins and antihypertensives top the safety ranking with 30-plus years of data; growth hormone and testosterone 'optimisation' rank lowest, with real harm.